retatrutide available in uk 20mg Retatrutide 20mg Pen | Research

These results will determine whether retatrutide gets approved, and for which uses

Will retatrutide be marketed in France in 2026

GLP-1 Receptor Agonist Market Report 2026 Global Outlook By Drug Class (Exenatide, Liraglutide, Dulaglutide, Lixisenatide, Other Drugs), By Route Of Administration (Parenteral, Oral), By End Users (Hospitals, Surgical Clinics, Other Users) Market Size, Trends, Strategies, and Forecast to 2035 GLP-1 Receptor Agonist Market Overview GLP-1 Receptor Agonist market size has reached to $14.09 billion in 2025 Expected to grow to $18.32 billion in 2030 at a compound annual growth rate (CAGR) of 5.4% Growth Driver: Surging Diabetes Cases Fuel Growth In Glp-1 Receptor Agonist Market Market Trend: Sustained-Release Glp-1 Receptor Agonists Are Gaining Popularity North America was the largest region in 2025 and Asia-Pacific is the fastest growing region

GLP-1 Receptor Agonist Market Trends The market is expected to witness strong growth through 2032, driven by increasing interest in drugs with multiple administration routes and improved drug efficacy

The STEP 1 trial published in the New England Journal of Medicine in 2021 showed 14.9% mean weight loss at 68 weeks

Fridays co-founder, Dr